102 matches.
- PublicationsNavigating Pharmacy Models and Regulatory Pitfalls When Launching Direct-to-Consumer Programs2 minute read
- Media CoverageAlan Arville Quoted in “More Transparency, Definitions Needed Around 340B Program”6 minute read
- BlogsFederal Appellate Court Upholds Mississippi 340B Contract Pharmacy Protections8 minute read
- PublicationsPreparing for the Medicare Transaction Facilitator1 minute read
Firm AnnouncementsEpstein Becker Green Attorneys Honored for Excellence in the Legal Profession by Best Lawyers 202612 minute read- BlogsHRSA Seeks Applicants to Test 340B Rebate Model Pilot Program8 minute read
- Firm AnnouncementsEpstein Becker Green Earns Top Honors in Legal 500 2025 for Excellence in Client Service and Achievements Across Key Health Care, Employment, and Transactional Practices3 minute read
- EventsJune 2025 Advantage+ Update1 minute read
Firm AnnouncementsEpstein Becker Green Recognized by Chambers USA 2025 for Delivering Excellence on Behalf of Healthcare, Labor & Employment, and White Collar Litigation Clients5 minute read- EventsOhio Hospital Association's 110th Annual Meeting & Education SummitMay 19–21, 20252 minute read
- BlogsMedicare Drug Price Negotiation Program: The Inflation Reduction Act “Pill Penalty” and Other IRA Reforms on the Horizon for 20267 minute read
- BlogsAs State Legislatures Debate Strengthening the Corporate Practice of Medicine Limitations, a Drug Manufacturer’s Lawsuits Shine a Light on the Relationship Between Telehealth Companies and Affiliated Medical Groups8 minute read
- EventsAMCP 2025: Understanding 340B Stakeholder Perspectives, Litigation Trends, and Reform Prospects2 minute read
- BlogsDEA Telemedicine Rules Further Delayed Until (Nearly) 20263 minute read
- BlogsEffective Dates of DEA Final Rules for Telemedicine Prescribing Delayed3 minute read
- BlogsThe 340B Reimbursement Battle: What Hospitals and Insurers Need to Know14 minute read
- BlogsAt Long Last, DEA’s Remote Prescribing Rules 2.0 Are (Really) Here! (Pending Further Consideration by the Incoming Administration . . .)18 minute read
- BlogsCMS Rules Propose Changes Regarding the Medicare Prescription Drug Inflation Rebate Program, Refundable Drugs, Skin Supplements and More; Comments Due September 913 minute read
- Firm AnnouncementsEpstein Becker Green Attorneys Honored for Excellence in the Legal Profession by Best Lawyers 202514 minute read
-
Firm AnnouncementsEpstein Becker Green Honored for Exceptional Performance in Key Practice Areas by Chambers USA 20245 minute read
- EventsAPhA2024: The Inflation Reduction Act - Implications for Pharmacy2 minute read
- Events340B Coalition Winter Conference 2024: Contract Pharmacy Deeper Dive1 minute read
- PublicationsHospital and MA Plan Considerations for CMS Final Rule to Remedy 340B Drug Payment Policy11 minute read
- PublicationsIn Genesis Case, South Carolina District Court Scraps HRSA Interpretation of “Patient” Under 340B Statute9 minute read
- PublicationsState Regulation of Pharmacy Benefit Managers: Tenth Circuit Holds That ERISA and Medicare Part D Preempt Key Parts of Oklahoma PBM Law25 minute read
- Firm AnnouncementsEpstein Becker Green Attorneys Recognized by 2024 Best Lawyers for Excellence in the Legal Profession12 minute read
Firm AnnouncementsEpstein Becker Green Recognized for Focused Excellence Across Core Practice Areas in Chambers USA 20235 minute read- BlogsMore Federal Action in the Pharmaceutical Sector as PBM Bill Advances in the Senate12 minute read
- PublicationsCMS’s Initial Guidance on Medicare Drug Price Negotiation Program Suggests Familiar Pharmacy Chargeback Process12 minute read
- BlogsThe Wait Is Over . . . Or Is It? DEA’s Proposed Rules Around Telemedicine Prescribing: Initial Impressions and Key Takeaways21 minute read
- EventsAmerican Society for Pharmacy Law: Trends in Drug Spending, Pricing, and Pharmacy Reimbursement2 minute read
- PublicationsCongressional Legislation Seeks to Ensure “Equitable Treatment” in the 340B Program2 minute read
- PublicationsMore Changes in Store for Pharmaceutical Supply Chain Following Passage of Inflation Reduction Act18 minute read
Firm AnnouncementsEpstein Becker Green Attorneys Recognized by 2023 Best Lawyers for Excellence in the Legal Profession11 minute read- Events340B Coalition Summer Conference: Contract Pharmacy Compliance—Oversight by the EntityAugust 2, 20222 minute read
- PublicationsFTC’s PBM Study Signals Broader Federal Scrutiny of the Prescription Drug Sector23 minute read
- EventsAmerican Society for Pharmacy Law: An Overview of Changes to Claw Backs in CMS’ Part D Final Rule2 minute read
- EventsMedication Intelligence Summit 2022: Pharmacy Procurement Trends and GapsJune 7, 20222 minute read
-
Firm AnnouncementsChambers USA 2022 Recognizes Epstein Becker Green's Focused Excellence in Core Practice Areas: Distinguished in Healthcare, Labor & Employment, and Litigation4 minute read
- PublicationsCMS Finalizes Changes to Pharmacy DIR in Part D Starting with Contract Year 202414 minute read
- Firm AnnouncementsFifty-Eight Epstein Becker Green Attorneys Recognized for Professional Excellence–Three Attorneys Distinguished as “Lawyer of the Year”–by The Best Lawyers in America 20227 minute read
- Events340B Coalition Summer Conference 2021: Contract Pharmacy Basics1 minute read
- PublicationsFinalized HHS Drug Formulary Rebate Rule Faces Uncertain Future Under Biden Administration and Current Legal Challenge20 minute read
- PublicationsLowering Drug Prices with the Anti-Kickback Statute: Future and Impact of HHS Final Rule to Disrupt Drug Formulary Rebates2 minute read
- Media CoverageAlan Arville Quoted in “340B Provider Camp Cheers HHS Letter to Lilly, Pharma Camp Says the Fight Isn’t Over”2 minute read
- PublicationsPresident Trump Signs Executive Orders on Drug Pricing and Domestic Supply Chain Reform22 minute read
- PublicationsStates Are Questioning Medicaid MCO Rx Benefits3 minute read
- PublicationsA Chance for Pharmacies to Showcase Health Care Services2 minute read
- BlogsFace or Fingerprint? The DEA Revisits Biometric Identifiers for e-Prescribing Controlled Substances4 minute read
- EventsAPhA2020: The Drug Cost Controversy, Part 2 – What's Next?1 minute read
- EventsRetail and Specialty Pharmacy: Strategic and Regulatory Considerations for Expanding Hospital Pharmacy Options1 minute read
- PublicationsTelehealth Growth = Expansion of Fraud & Abuse Enforcement2 minute read
- EventsHHS OIG Proposed Rule on the Safe Harbor for Pharmaceutical Rebates: The Issues and Impact2 minute read
- EventsDrug Pricing and Reimbursement: 2018 in Review and Outlook for 20192 minute read
- PublicationsHHS OIG Proposes Anti-Kickback Safe Harbor Amendments to Regulate and Restrict the Provision of Manufacturer Remuneration to Plan Sponsors and PBMs19 minute read
- PublicationsCMS Releases Medicare Advantage and Part D Drug Pricing Proposed Rule for Contract Year 202028 minute read
- BlogsHRSA Establishes January 1, 2019 Effective Date for 340B Ceiling Price and Civil Monetary Penalty Rule3 minute read
- BlogsNew Federal Laws Banning “Gag Clauses” in the Pharmacy4 minute read
- Events340B Drug Pricing Program: Past, Present and Future1 minute read
- BlogsCMS Finalizes Policy and Technical Changes to the Medicare Advantage and Part D Programs for CY 20195 minute read
- Events340B Coalition Winter Conference: Contract Pharmacy Arrangements1 minute read
- BlogsWhite House 2019 Budget and White Paper Shape Ambitious Policy to Reduce Drug Prices8 minute read
- PublicationsComment Deadline Approaches for CMS's Proposed Changes to Medicare Advantage and Part D Programs for CY 2019 – Part 2: Beneficiary Cost, Access, and Protection21 minute read
- BlogsCMS Final Rule Will Reduce Medicare Part B Drug Payments by Nearly 30% for 340B Hospitals5 minute read
Videos & Podcasts- EventsASPL: 340B Drug Discount Program: Evolving Compliance Standards for Covered Entities and Contract Pharmacies in Wake of Proposed 340B Mega Guidance and Orphan Drug Ruling1 minute read
- PublicationsPaul Gomez, Katherine Lofft, Alan Arville Contributed to AHLA Representing Hospitals and Health Systems Handbook1 minute read
- Events340B Coalition 20th Annual Summer Conference2 minute read
- EventsAHLA Physicians and Hospitals Law Institute2 minute read
- PublicationsCMS Issues Final Rule on Covered Outpatient Drugs38 minute read
- BlogsU.S. District Court Vacates HRSA's Interpretative Rule on Orphan Drugs9 minute read
- Events2015 MDRP Summit: Addressing Key Areas Covered Within the 340B "Omnibus Guidance"1 minute read
- Media CoverageAlan Arville Quoted in "Attorneys Have Concerns with 340B Program Guidance"2 minute read
- BlogsHRSA Issues Proposed "Omnibus Guidance"11 minute read
- Events340B Coalition Annual Conference: Third-Party Billing & Reimbursement Roundtable1 minute read
- Events340B Coalition Annual Conference: Panel for 340B Service Providers1 minute read
- Events340B Coalition Annual Conference: Contract Pharmacy Interest Group1 minute read
- PublicationsHouse Energy and Commerce Committee Proposes, then Drops, 340B Reform Language to 21st Century Cures Legislation1 minute read
- BlogsHouse Energy and Commerce Committee Proposes, then Drops, 340B Reform Language to 21st Century Cures Legislation4 minute read
- PublicationsConstance Wilkinson, Alan Arville Comment on Specialty Drug Cost Upswing2 minute read
- PublicationsMembers of House Subcommittee Express Support for the 340B Program, but Need for Clarity, Oversight and Transparency1 minute read
- BlogsMembers of House Subcommittee Express Support for the 340B Program, but Need for Clarity, Oversight and Transparency6 minute read
- Events340B Coalition Winter Conference1 minute read
- BlogsHRSA Withdraws 340B "Mega-Reg;" Plans to Issue Guidance in 20156 minute read
- EventsHot Topics in Pharmacy Compliance and Enforcement1 minute read
- PublicationsOIG Warns Pharmaceutical Manufacturers of Improper Part D Beneficiary Coupon Use9 minute read
- BlogsHRSA Issues Interpretive Rule on 340b Orphan Drug in Response to Court Vacating Final Rule7 minute read
- Events340B Coalition Conference: 340B Contract Pharmacy Basics1 minute read
- PublicationsCMS Scaled Back Changes to the Medicare Part D Prescription Drug and Medicare Advantage Programs, but Some Important Revisions Remain11 minute read
- EventsHealth Care Transactions: 340B Program Considerations for Acquisitions and Contract Pharmacy Arrangements1 minute read
- EventsStructuring 340B Contract Pharmacy Arrangements: Meeting Legal and Regulatory Requirements2 minute read
- PublicationsMore Contract Pharmacy Oversight for HHS 340B Program, inLaw3602 minute read
- BlogsMajor Themes at 340B Coalition Winter Conference Include Contract Pharmacy Oversight, Medicaid Managed Care, and Anticipated 340B "Mega-Reg"7 minute read
- BlogsOIG Issues Report on 340B Contract Pharmacy Arrangements Supporting Need for Tighter Rules6 minute read
- Events340B Coalition Winter Conference: 340B Contract Pharmacies and Pharmacy Service Providers2 minute read
- PublicationsCMS Proposes Far-Reaching Changes to the Medicare Part D Prescription Drug Benefit Program and the Medicare Advantage Program23 minute read
- EventsNCPA 115th Annual Convention: 340B Contracting Essentials and Best Practices1 minute read
- Firm AnnouncementsEpstein Becker Green Expands National Health Care and Life Sciences Practice with Alan J. Arville2 minute read
- Events340B Programs in Disproportionate Share Hospitals: What to Expect and How to Cope With Inquiries from HRSA, Manufacturers, and Senator Grassley1 minute read
- Events340B Basics: An Introduction to 340B Compliance and Contract Pharmacy Arrangements1 minute read
- Events340B Contract Pharmacy Arrangements: A Strafford Publications Webinar1 minute read
- PublicationsImportant Considerations in Negotiating a Managed Care Contract: The Provider Perspective, in BNA's Health Law Resource Center1 minute read